Valentino J. Stella

School of Pharmacy - Pharmaceutical Chemistry
University Distinguished Professor
Primary office:
Simons Biosciences Research Laboratories
Room 121A
University of Kansas
2095 Constant Ave
Lawrence, KS

Expertise and Current Research Activity

My research involves novel ways of formulating and delivering to the body, problematic drug candidates, especially drugs used to treat cancer and AIDs. I am also the inventor or co-inventor of the drugs fosphenytoin (Cerebyx®), Viread®, Lusedra® and Captisol® the solubilizer used in the injectable forms of Vfend®, Geodon®, Abilify®, Nexterone® and the veterinary product Cerenia® and helped formulate the novel anticancer drug Velcade®.

I helped found three Kansas companies, Cydex Pharma, Crititech and ProQuest Pharma. All of the products are helping Kansans and others throughout the world live healthy and productive lives. I also helped establish the biosciences incubator in Lawrence and I am involved with the National Cancer Center designation for the University of Kansas.


Ph.D., Analytical Pharmaceutical Chemistry and Pharmaceutics, University of Kansas

B. Pharm., Victorian College of Pharmacy


General research interests might be defined as the application of physical organic chemistry to solving pharmaceutical problems (prodrugs, drug stability, biopharmaceutics and pharmacokinetics, especially as they relate to prodrugs, dissolution and other phase transport phenomena, etc. Specifically:

1. Prodrugs.

2. Novel drug delivery systems.

3. Preformulation studies on parenteral cytotoxic and antiAIDs drugs.

4. Development and assessment of novel, modified cyclodextrins.

5. Sulfenamides as prodrugs.

6. Novel peroxide scavengers

Research Interests

  • Prodrugs
  • Drug stability
  • Cyclodextrins
  • Drug formulation

One of 34 U.S. public institutions in the prestigious Association of American Universities
44 nationally ranked graduate programs.
—U.S. News & World Report
Top 50 nationwide for size of library collection.
23rd nationwide for service to veterans —"Best for Vets," Military Times
KU Today